type-1-diabetes

Documents about type-1-diabetes

• Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes#280246HAL (France)
• Evaluation of an Early Screener to Identify Long-term Problems With Regard to Metabolic Control and Treatment Adherence Among Children and Adolescents With Type 1 Diabetes#287481ClinicalTrials.gov
• Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)#377367ClinicalTrials.gov
• National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes#674856ClinicalTrials.gov
• Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance#463672ClinicalTrials.gov
• Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose#363550ClinicalTrials.gov
• MRI Imaging of Labeled Human Islets Transplanted Into the Liver#805860ClinicalTrials.gov
• GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake#136273ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#272322ClinicalTrials.gov
• Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus#303688ClinicalTrials.gov
• Predictive and Protective Factors in the Cause of Diabetes - A Study in Twins#394722ClinicalTrials.gov
• MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes#377343ClinicalTrials.gov
• The Effect of Diabetes Education Digital Games and Video Animation on Quality of Life#136222ClinicalTrials.gov
• Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients (PLATEDIAN)#356599ClinicalTrials.gov
• Perceptions of adults with type 1 diabetes mellitus about diabetes management and exercise.#416129PubMed
• Automated Insulin for Management of Intrapartum Glycemia#417498ClinicalTrials.gov
• School performance of children with type 1 diabetes mellitus : a systematic review#631550Repositório Institucional da UnB
• A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes#377361ClinicalTrials.gov
• Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)#805031ClinicalTrials.gov
• The Role of South Asian vs European Origins on Circulating Regenerative Cell Exhaustion#448229ClinicalTrials.gov
• Use of Santyl Within an Accountable Care Organization#801554ClinicalTrials.gov
• Assessing Plasma C-Peptide Levels and Their Relationship with Health-Related Quality of Life in Patients with Prediabetes and Type 1 and Type 2 Diabetes#229964Zenodo (CERN)
• Predicting Postprandial Glycemic Responses With Limited Data in Type 1 and Type 2 Diabetes#372151PubMed Central
• GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#154871ClinicalTrials.gov
• A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes#369959ClinicalTrials.gov
• A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers#448204ClinicalTrials.gov
• Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA#329452ClinicalTrials.gov
• HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D)#67763ClinicalTrials.gov
• Bigfoot Biomedical Clinical Research Center (CRC) Trial#126007ClinicalTrials.gov
• Effect of GLP-1 on Angiogenesis#184819ClinicalTrials.gov
• Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study#230325ClinicalTrials.gov
• Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes#356524ClinicalTrials.gov
• Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability#377350ClinicalTrials.gov
• Adaptive Biobehavioral Control (ABC) in a Closed-Loop System#422392ClinicalTrials.gov
• Performance Study of the SOLO 2.0 Insulin Pump#426737ClinicalTrials.gov
• Faster Aspart on Insulin-pump Treated T1DM Patients#429693ClinicalTrials.gov
• Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength#435690ClinicalTrials.gov
• Meal Handling of Advanced Closed Loop Insulin Delivery.#460039ClinicalTrials.gov
• Telemedicine Monitoring of Nocturnal Incidents#460048ClinicalTrials.gov
• Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes#121265ClinicalTrials.gov
• Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded Hybrid Closed Loop System#272303ClinicalTrials.gov
• Comparison of the Use of Energy Substrates and Hormonal Regulation of Blood Sugar During Exercise of Increasing Intensity Between Children With Type 1 Diabetes and Non-diabetic Control Children.#321643ClinicalTrials.gov
• The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus#481709ClinicalTrials.gov
• Gingival Crevicular IL-34 and CSF-1 Levels in Patients With Periodontitis and Uncontrolled Type 2 Diabetes#217197ClinicalTrials.gov
• A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections#300407ClinicalTrials.gov
• Continuous Glucose Monitoring Initiation at Hospital Discharge#424334ClinicalTrials.gov
• Evaluation of HbA1c Levels and Ovarian Reserve and Type 1 Diabetes#628654ClinicalTrials.gov
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy#158154ClinicalTrials.gov
• Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes#230367ClinicalTrials.gov
• Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease#481700ClinicalTrials.gov